The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)
NCT01825161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 454
Last updated 2022-09-13
Summary
The main purpose of this study is to utilize a comprehensive, prospective clinical database to collect patient, diagnostic and treatment variables along with disease specific and generic health related quality of life (HRQOL) data on consecutively treated patients with metastatic spine tumors. The objectives are to determine the validity and reliability of the Spine Cancer Outcomes Questionnaire (SCOQ) for use in the assessment of spine tumor outcomes, to determine if the Spine Instability Neoplastic Score (SINS) Classification is a valid tool for predicting the stability of spine in metastatic spine disease, and to determine the efficacy of surgery versus radiotherapy for the treatment of impending instability secondary to metastatic disease of the spine.
Conditions
- Secondary Malignant Neoplasm of Vertebral Column
Sponsors & Collaborators
-
Orthopaedic Research Foundation
collaborator OTHER -
AO Foundation, AO Spine
lead OTHER
Principal Investigators
-
Charles G Fisher, MD · Vancouver General Hospital and the University of British Columbia
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
- Canada
- Hungary
Study Locations
More Related Trials
-
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002521 ·Status: COMPLETED ·Phase: PHASE2
-
Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer
NCT01407341 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00002522 ·Status: COMPLETED ·Phase: PHASE2
-
The Myeloid Neoplasms Biology and Outcome Project
NCT05074316 ·Status: RECRUITING
-
Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma
NCT02517918 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT00002508 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
NCT03442465 ·Status: RECRUITING
-
ERAS Anesthetic Care for Metastatic Spine Cancer Resection
NCT05427825 ·Status: UNKNOWN ·Phase: NA
-
A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma
NCT04316091 ·Status: UNKNOWN ·Phase: PHASE1
-
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy
NCT00554918 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
NCT00004231 ·Status: COMPLETED ·Phase: PHASE2
-
European Study in Bone Sarcoma Patients Over 40 Years
NCT02986503 ·Status: COMPLETED
-
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
NCT00238368 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
NCT00003101 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00005613 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
NCT00002931 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors
NCT00002619 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00002552 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
NCT00559104 ·Status: COMPLETED ·Phase: PHASE2
-
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
NCT00874211 ·Status: COMPLETED
-
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00003401 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
NCT00002509 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
NCT00002601 ·Status: COMPLETED ·Phase: PHASE2
-
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
NCT06492954 ·Status: RECRUITING ·Phase: PHASE1
-
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
NCT00429507 ·Status: COMPLETED ·Phase: PHASE2